Skip to main content
Signal8
Macfarlane K. Angela profile photo

K. Angela Macfarlane

CIK: 0001865182

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

RenovoRx, Inc. logo
RNXT

RenovoRx, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • RenovoRx, Inc. logo
    RNXT

    RenovoRx, Inc.

    Oct 1, 2026
    Award(A)

    Stock Options (right to buy)

    Direct
    55.9K shares-
  • RenovoRx, Inc. logo
    RNXT

    RenovoRx, Inc.

    Oct 1, 2025
    Award(A)

    Stock Options (right to buy)

    Direct
    47.6K shares-
  • RenovoRx, Inc. logo
    RNXT

    RenovoRx, Inc.

    Oct 1, 2024
    Award(A)

    Stock Options (right to buy)

    Direct
    25.1K shares-

1-3 of 3

About Macfarlane K. Angela

Macfarlane K. Angela (SEC CIK 0001865182) files insider reports with the SEC as Director of RenovoRx, Inc. (RNXT).

Signal8 holds 3 ownership filings by Macfarlane K. Angela, all Form 4s, filed between Oct 2, 2024 and Oct 2, 2026. Those filings report 3 transactions, from Oct 1, 2024 to Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Macfarlane K. Angela's filings is in MOUNTAIN VIEW, CA.

Recent filings by Macfarlane K. Angela

  • Oct 1, 2026: Grant or award of RNXT derivative securities (Form 4, code A).
  • Oct 1, 2025: Grant or award of RNXT derivative securities (Form 4, code A).
  • Oct 1, 2024: Grant or award of RNXT derivative securities (Form 4, code A).

Other insiders filing for RenovoRx, Inc. (RNXT)

How to read Form 4 transaction codes